XML 85 R54.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair Value of Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following tables set forth the financial instruments that were measured at fair value on a recurring basis by level within the fair value hierarchy as of December 31, 2023 and 2022 (in thousands):
December 31, 2023
Total Fair
Value
Level 1Level 2Level 3
Cash equivalents:
Money market funds(1)
$184,259 $184,259 $— $— 
Commercial paper(1)
— — — — 
Total cash equivalents$184,259 $184,259 $— $— 
December 31, 2022
Total Fair
Value
Level 1Level 2Level 3
Cash equivalents:
Money market funds(1)
$45,739 $45,739 $— $— 
Commercial paper(1)
1,991 — 1,991 — 
Total cash equivalents47,730 45,739 1,991 — 
Marketable securities:
U.S. treasuries(2)
65,391 65,391 — — 
Commercial paper(2)
115,061 — 115,061 — 
U.S. agency securities(2)
53,455 — 53,455 — 
Asset-backed securities(2)
1,914 — 1,914 — 
Total marketable securities235,821 65,391 170,430 — 
Total cash equivalents and marketable securities$283,551 $111,130 $172,421 $— 
__________________
(1)Included within cash and cash equivalents on the balance sheet.
(2)Included within investments in marketable securities, current and investments in marketable securities, non-current on the balance sheet.
Liabilities measured at fair value on a recurring basis are as follows (in thousands):
Fair Value Measurements at Reporting Date
TotalLevel 1Level 2Level 3
At December 31, 2022:
Liabilities
Preferred stock warrants liability
$994 $— $— $994 
Total liabilities measured at fair value
$994 $— $— $994 
Fair Value Measurements at Reporting Date
TotalLevel 1Level 2Level 3
At December 31, 2023:
Cash equivalents
Money market funds
$7,962 $7,962 $— $— 
Total cash equivalents measured at fair value
$7,962 $7,962 $— $— 
Marketable securities
Commercial paper
$18,751 $— $18,751 $— 
U.S. government agency securities
9,925 — 9,925 — 
U.S. treasury securities
1,978 1,978 — — 
Total marketable securities measured at fair value
$30,654 $1,978 $28,676 $— 
Liabilities
Preferred stock warrants liability
$871 $— $— $871 
Total liabilities measured at fair value
$871 $— $— $871 
Schedule of Marketable Securities
The Company did not hold any marketable securities as of December 31, 2023. The amortized cost, gross unrealized holding gains or losses, and fair value of the Company’s marketable securities by major security type as of December 31, 2022 are summarized in the table below (in thousands):
December 31, 2022
Amortized
Cost Basis
Unrealized
Gains
Unrealized
Losses
Fair
Value
Available-for-sale securities
U.S. treasuries$65,807 $— $(416)$65,391 
Commercial paper115,381 13 (333)115,061 
U.S. agency securities53,767 15 (327)53,455 
Asset-backed securities1,914 — — 1,914 
Total available-for-sale securities$236,869 $28 $(1,076)$235,821 
Marketable securities consisted of the following (in thousands):
December 31, 2023
Amortized CostGross Unrealized GainsGross Unrealized LossesEstimated Fair Value
Commercial paper
$18,742 $$— $18,751 
US government agencies
9,927 (3)9,925 
US treasury securities
1,977 — 1,978 
Totals
$30,646 $11 $(3)$30,654 
Schedule of Fair Value Measurement Inputs and Valuation Techniques
The key unobservable inputs for the preferred stock warrants liability were:
December 31
20222023
Estimated time to liquidity
2.5 years2.0 years
Volatility rate
70.0%84.0%
Risk-free interest rate
4.3%4.2%
Schedule of Preferred Stock Warrant Liability Activity
The following table presents activity for the preferred stock warrants liability during the years ended December 31, 2023 (in thousands):
Preferred Stock Warrants Liability
Balance at December 31, 2022
$994 
Change in fair value
(123)
Balance at December 31, 2023
$871